| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6194353 | Urologic Oncology: Seminars and Original Investigations | 2014 | 6 Pages |
Abstract
Only 2% of patients relapsing after radiation therapy for localized prostate cancer received LST. Although the benefits of LST are unproven, these findings reveal a possible underutilization of LST and indicate a need for enhanced collaboration between specialties to optimize care of this challenging cohort.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Henry M.D., Jaime Kwok, Tom M.D., Scott M.D., Peter C. M.D.,